Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 451-460 of 6864

Page
per page
  1. NPEC-caged-(1S,3R)-ACPD
    B7369 NPEC-caged-(1S,3R)-ACPD
    Summary: group I and II mGlu receptor agonist
      insoluble in H2O; <36.63 mg/mL
  2. Atglistatin
    B3021 Atglistatin
     1 Citation
    Target: ATGL
    Summary: ATGL inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥14.15 mg/mL
  3. Daunorubicin HCl
    B2285 Daunorubicin HCl
    Summary: DNA topoisomerase II inhibitor
      ≥28.2 mg/mL
  4. 4-Bromo-3-hydroxybenzoic acid
    C7021 4-Bromo-3-hydroxybenzoic acid
      ≥21.3 mg/mL
  5. Metergoline
    B6365 Metergoline
    Summary: 5-HT1/5-HT2 antagonist
      Soluble in DMSO
  6. AH 11110 hydrochloride
    B6541 AH 11110 hydrochloride
    Summary: α1B-AR ligand,subtype-selective
      Soluble to 25 mM in H2O
  7. Citalopram hydrobromide
    B6736 Citalopram hydrobromide
    Summary: 5-HT uptake inhibitor
  8. NPEC-caged-(S)-3,4-DCPG
    B7368 NPEC-caged-(S)-3,4-DCPG
    Summary: mGlu8a agonist
      <43.23 mg/mL
  9. Tacrolimus (FK506)
    B2143 Tacrolimus (FK506)
     9 Citation
    Target: Peptidylprolyl isomerases
    Summary: calcineurin inhibitor
      ≥26.6 mg/mL
  10. cis-Flupenthixol (hydrochloride)
    C5314 cis-Flupenthixol (hydrochloride)
    Summary: antagonist at dopamine D2 receptors
      ≤1 mg/mL

Items 451-460 of 6864

Page
per page